Literature DB >> 25664

Exacerbations of chronic bronchitis: exogenous or endogenous infection?

D A Ellis, I M Anderson, S M Stewart, J Calder, J W Crofton.   

Abstract

Six male patients with chronic bronchitis, who were known previously to have excreted Streptococcus pneumoniae and/or Haemophilus influenzae, both at the times of exacerbations and during remission, were studied for 43 to 52 months. Sputum was examined fortnightly and at the time of exacerbations. Strains of Strep. pneumoniae were serotyped and those of Haemophilus species were typed by antibiograms along with other supporting methods. Sera collected before or at the time of an exacerbation and seven and 30 days afterwards were examined by complement fixation tests against respiratory viruses and Mycoplasma pneumoniae. In 18 out of 25 exacerbations there was evidence of a new type of Strep. pneumoniae and/or Haemophilus spp. or of a current virus infection, suggesting exogenous infection in the majority of these cases. There was a possible reason for failure to detect a new pathogen in three of the seven cases in which none was found. In five further exacerbations adequate investigation was not possible.

Entities:  

Mesh:

Year:  1978        PMID: 25664     DOI: 10.1016/0007-0971(78)90020-7

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  4 in total

1.  Haemophilus biotypes in respiratory disease.

Authors:  G B Rhind; G A Gould; F Ahmad; M J Croughan; M A Calder
Journal:  Thorax       Date:  1987-02       Impact factor: 9.139

2.  S. pneumoniae: important contributor to morbidity and mortality in patients with chronic obstructive pulmonary disease--fact or fiction?

Authors:  A L Davis; C P Aranda; L C Christianson
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

3.  Tracheal function during influenza infections.

Authors:  K M Nugent; E L Pesanti
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

Review 4.  Office management of lower respiratory infections in adults.

Authors:  R E Van Scoy
Journal:  Med Clin North Am       Date:  1983-01       Impact factor: 5.456

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.